2018 | Page 10 of 10 | Cancer Today

Online Discussions Reveal Little-Known Side Effects

Analyzing online patient conversations could shed light on adverse drug reactions.

by Brad Jones
Is 3-D Mammography Better?

A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography.

by Marci A. Landsmann
When Cancer Survivors Get Another Cancer

Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.

by Kate Yandell

Chemotherapy Essentials

Stock your bag with these useful items before your next infusion session.

by Jamie L. Schwachter
Welcome to Our New Website

An updated site and a new digital editor means better and faster cancer coverage for our readers.

by Cancer Today Staff

Previous |

Cancer Talk

Immunotherapy Improves Survival in Bladder Cancer

New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.

by Laura Gesualdi-Gilmore

Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live Longer

Findings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.

by Kyle Bagenstose

Delaying Treatment Resistance

Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.

by Thomas Celona

2024: The Year in Cancer News

The Cancer Today editors share the most impactful reporting on cancer research from 2024.

by Cancer Today staff

Cancer Talk Archive

Cancer Talk Topics

CLEAR FILTERS

From the AACR

AACR Grant Propels Progress in Immunotherapy Research

A grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
Self-screening for Cancer: Home Sweet Home

New cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.

Video

Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial